Mitochondrial Dysfunction Contributes to Aging-Related Atrial Fibrillation
- PMID: 34007402
- PMCID: PMC8102104
- DOI: 10.1155/2021/5530293
Mitochondrial Dysfunction Contributes to Aging-Related Atrial Fibrillation
Abstract
The incidence of atrial fibrillation (AF) increases with age, and telomere length gradually shortens with age. However, whether telomere length is related to AF is still inconclusive, and the exact mechanism by which aging causes the increased incidence of AF is still unclear. We hypothesize that telomere length is correlated with aging-related AF and that mitochondrial dysfunction plays a role in this. This research recruited 96 elderly male patients with AF who were admitted to the Second Medical Center of Chinese PLA General Hospital from April to October 2018. After matching by age and gender, 96 non-AF elderly male patients who were admitted to the hospital for physical examination during the same period were selected as controls. Anthropometric, clinical, and laboratory analyses were performed on all subjects. The mitochondrial membrane potential (MMP) of peripheral blood leukocytes was detected as the indicator of mitochondrial function. Compared with the control group, the leukocyte telomere length (LTL) was significantly shorter (P < 0.001), and the level of PGC-1α in serum was significantly lower in AF patients. Additionally, in subjects without any other diseases, the AF patients had lower MMP when compared with the control. Multivariate logistic regression confirmed that LTL (OR 0.365; 95% CI 0.235-0.568; P < 0.001) and serum PGC-1α (OR 0.993; 95% CI 0.988-0.997; P = 0.002) were inversely associated with the presence of AF. In addition, ROC analysis indicated the potential diagnostic value of LTL and serum PGC-1α with AUC values of 0.734 and 0.633, respectively. This research concludes that LTL and serum PGC-1α are inversely correlated with the occurrence of aging-related AF and that mitochondrial dysfunction plays a role in this.
Copyright © 2021 Chuanbin Liu et al.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.
Figures
Similar articles
-
Telomere length and the risk of atrial fibrillation: insights into the role of biological versus chronological aging.Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1026-32. doi: 10.1161/CIRCEP.114.001781. Epub 2014 Nov 8. Circ Arrhythm Electrophysiol. 2014. PMID: 25381796 Free PMC article.
-
Study on the relationship between telomere length changes and recurrence of atrial fibrillation after radiofrequency catheter ablation.J Cardiovasc Electrophysiol. 2019 Jul;30(7):1117-1124. doi: 10.1111/jce.13958. Epub 2019 May 29. J Cardiovasc Electrophysiol. 2019. PMID: 31042327
-
Association Between Leukocyte Telomere Length and the Risk of Incident Atrial Fibrillation: The Framingham Heart Study.J Am Heart Assoc. 2017 Nov 14;6(11):e006541. doi: 10.1161/JAHA.117.006541. J Am Heart Assoc. 2017. PMID: 29138179 Free PMC article.
-
Association between leucocyte telomere length and the risk of atrial fibrillation: An updated systematic review and meta-analysis.Ageing Res Rev. 2022 Nov;81:101707. doi: 10.1016/j.arr.2022.101707. Epub 2022 Aug 3. Ageing Res Rev. 2022. PMID: 35932977 Review.
-
Leucocyte telomere length and paroxysmal atrial fibrillation: A prospective cohort study and systematic review with meta-analysis.J Clin Lab Anal. 2018 Nov;32(9):e22599. doi: 10.1002/jcla.22599. Epub 2018 Jun 26. J Clin Lab Anal. 2018. PMID: 29943516 Free PMC article. Review.
Cited by
-
β-Hydroxybutyrate and Citrate Synthase as Potential Diagnostic Biomarkers in Aging-Related Atrial Fibrillation.J Cardiovasc Transl Res. 2024 Nov 5. doi: 10.1007/s12265-024-10569-9. Online ahead of print. J Cardiovasc Transl Res. 2024. PMID: 39499445
-
Causal gene identification using mitochondria-associated genome-wide mendelian randomization in atrial fibrillation.Front Pharmacol. 2024 Jul 29;15:1439816. doi: 10.3389/fphar.2024.1439816. eCollection 2024. Front Pharmacol. 2024. PMID: 39135799 Free PMC article.
-
SGLT2 Inhibitors in Aging-Related Cardiovascular Disease: A Review of Potential Mechanisms.Am J Cardiovasc Drugs. 2023 Nov;23(6):641-662. doi: 10.1007/s40256-023-00602-8. Epub 2023 Aug 24. Am J Cardiovasc Drugs. 2023. PMID: 37620652 Review.
-
Identification of key genes increasing susceptibility to atrial fibrillation in nonalcoholic fatty liver disease and the potential mechanisms: mitochondrial dysfunction and systemic inflammation.Front Pharmacol. 2024 Mar 14;15:1360974. doi: 10.3389/fphar.2024.1360974. eCollection 2024. Front Pharmacol. 2024. PMID: 38549670 Free PMC article.
-
DNA Methylation and Telomeres-Their Impact on the Occurrence of Atrial Fibrillation during Cardiac Aging.Int J Mol Sci. 2023 Oct 28;24(21):15699. doi: 10.3390/ijms242115699. Int J Mol Sci. 2023. PMID: 37958686 Free PMC article. Review.
References
-
- Fuster V., Rydén L. E., Cannom D. S., et al. 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: Journal of the American College of Cardiology. 2011;57(11):e101–e198. doi: 10.1016/j.jacc.2010.09.013. - DOI - PubMed
-
- Lee S.-R., Choi E.-K., Han K.-D., Cha M.-J., Oh S. Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the Cha2ds2-Vasc score in the entire Korean population. International Journal of Cardiology. 2017;236:226–231. doi: 10.1016/j.ijcard.2017.02.039. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous